Active Not Recruiting NCT06105151
This study is active but not recruiting in China. It is testing Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules for Schizophrenia.
In Beijing Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 60 Years
Countries China
Sponsor Vigonvita Life Sciences
Condition Schizophrenia Completed NCT00080327
This summary needs review. Please check the official study record and contact the research team for details.
In Wallingford Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT02248987
This summary needs review. Please check the official study record and contact the research team for details.
In Seoul Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational i A study where researchers collect information without assigning a treatment. From 20 Years to 55 Years
Countries South Korea
Sponsor Seoul National University Hospital
Condition Schizophrenia Completed NCT03379480
This summary needs review. Please check the official study record and contact the research team for details.
In Bangalore Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 45 Years
Countries India
Sponsor National Institute of Mental Health and Neuro Sciences, India
Condition Schizophrenia Completed NCT00759460
This summary needs review. Please check the official study record and contact the research team for details.
In Beijing Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries China
Sponsor H. Lundbeck A/S
Condition Schizophrenia Completed NCT01433094
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Urbino Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 55 Years
Countries Italy
Sponsor University of Cagliari
Condition Schizophrenia Terminated NCT00669903
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Garden Grove Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor AstraZeneca
Condition Schizophrenia Completed NCT02876900
This study is completed in the United States. It is testing HP3070 for schizophrenia.
In Jersey City Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States
Sponsor Noven Pharmaceuticals, Inc.
Condition Schizophrenia Completed NCT00921804
This study is completed in the United States. It is testing Efficacy, Safety, and Tolerability of AZD8529 for schizophrenia.
Multiple locations, including Garden Grove Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor AstraZeneca
Condition Schizophrenia Completed NCT02037074
This study is completed in the United States. It is testing Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen for schizophrenia.
In Long Beach Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries United States
Sponsor FORUM Pharmaceuticals Inc
Condition Schizophrenia Completed NCT03150771
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 64 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT04461119
This study is completed in the United States and in India. It focuses on schizophrenia.
Multiple locations, including Glendale Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States, India
Sponsor Newron Pharmaceuticals SPA
Condition Schizophrenia